Methods for cancer management targeting Co-029
US9040671B2 · kind B2 · utility
2Cited by
1References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 22, 2011 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Oct 20, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a Co-029 inhibitor for inhibiting the migration of cancer cells which express Co-029. The disclosure relates to a Co-029 inhibitor for the treatment of cancer and/or the prevention of cancer metastasis and pharmaceutical compositions comprising said inhibitor and provides Co-029 antibodies. The disclosure provides a method for predicting the response of a patient afflicted with or susceptible to be afflicted with cancer to a medical treatment with a Co-029 inhibitor, a method for diagnosing a cancer in a patient and a method for predicting the survival in a cancer patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.